Recombinant multi-species APOL1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine APOL1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a secreted high density lipoprotein which binds to apolipoprotein A-I. Apolipoprotein A-I is a relatively abundant plasma protein and is the major apoprotein of HDL. It is involved in the formation of most cholesteryl esters in plasma and also promotes efflux of cholesterol from cells. This apolipoprotein L family member may play a role in lipid exchange and transport throughout the body, as well as in reverse cholesterol transport from peripheral cells to the liver. Several different transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2008]
The Alternative Names of target: APO-L,APOL,APOL-I,APOL1,ApoL),Apolipoprotein L (Apo-L,Apolipoprotein L-I (ApoL-I),Apolipoprotein L1,FSGS4
Go
to APOL1 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-SE0024-Ag-1/ GM-Tg-hg-SE0024-Ag-2 | Human APOL1 protein | Human |
| GM-Tg-rg-SE0024-Ag-1/ GM-Tg-rg-SE0024-Ag-2 | Rat APOL1 protein | Rat |
| GM-Tg-mg-SE0024-Ag-1/ GM-Tg-mg-SE0024-Ag-2 | Mouse APOL1 protein | Mouse |
| GM-Tg-cynog-SE0024-Ag-1/ GM-Tg-cynog-SE0024-Ag-2 | Cynomolgus/Rhesus macaque APOL1 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-SE0024-Ag-1/ GM-Tg-felg-SE0024-Ag-2 | Feline APOL1 protein | Feline |
| GM-Tg-cang-SE0024-Ag-1/ GM-Tg-cang-SE0024-Ag-2 | Canine APOL1 protein | Canine |
| GM-Tg-bovg-SE0024-Ag-1/ GM-Tg-bovg-SE0024-Ag-2 | Bovine APOL1 protein | Bovine |
| GM-Tg-equg-SE0024-Ag-1/ GM-Tg-equg-SE0024-Ag-2 | Equine APOL1 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-SE0024-Ag-1/ GM-Tg-hg-SE0024-Ag-2;
GM-Tg-rg-SE0024-Ag-1/ GM-Tg-rg-SE0024-Ag-2;
GM-Tg-mg-SE0024-Ag-1/ GM-Tg-mg-SE0024-Ag-2; GM-Tg-cynog-SE0024-Ag-1/ GM-Tg-cynog-SE0024-Ag-2; GM-Tg-felg-SE0024-Ag-1/ GM-Tg-felg-SE0024-Ag-2; GM-Tg-cang-SE0024-Ag-1/ GM-Tg-cang-SE0024-Ag-2; GM-Tg-bovg-SE0024-Ag-1/ GM-Tg-bovg-SE0024-Ag-2; GM-Tg-equg-SE0024-Ag-1/ GM-Tg-equg-SE0024-Ag-2 |
| Products Name | APOL1 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | APOL1 |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine APOL1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.